Reuters
@Reuters·4.2M subscribers·86.9K videos
Pfizer steps up race for weight-loss drug
Posted
June 26, 2023
Views
1,933
Likes
25
Engagement
1.29%
June 26, 2023
1,933
25
1.29%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:23Now PlayingPfizer plans to discontinue its obesity drug lotiglipron and focus instead on its weight loss drug danuglipron as it races to rival the success of other weight loss treatments.
#News #Reuters #newsfeed #Pfizer #Weightloss #pharmaceutical #Ozempic
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
